| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |